Elixinol Wellness Limited (ELLXF)

0.0026 +0.0014 (+116.67%) As of 01:39PM EDT. Market open.

Elixinol Wellness Limited

680 George Street
Level 12
Sydney, NSW 2000
Australia
61 2 8280 7355
https://www.elixinolwellness.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Ms. Josephine Mary Lorenz	Group Chief Financial Officer	224.11k	N/A	N/A
Glen Zurcher	Account Director of Investor Relations Department	N/A	N/A	N/A
Ms. Natalie Butler	Head of Marketing & Executive Director	N/A	N/A	N/A
Mr. Tai Minh Phan	Joint Company Secretary	N/A	N/A	N/A
Ms. Melanie Leydin	Joint Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Elixinol Wellness Limited, through its subsidiaries, engages in the manufacture and distribution of hemp derived nutraceuticals, skincare, and food products in the Americas, Europe, and Australia. It offers hemp derived cannabidiol and food products, dietary supplements, topicals, and skincare products. The company was formerly known as Elixinol Global Limited and changed its name to Elixinol Wellness Limited in May 2021. The company was incorporated in 2017 and is headquartered in Sydney, Australia.

Corporate governance

Elixinol Wellness Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.